Inactive Instrument
Abliva AB Stock
Stocks
ABLI
SE0002575340
Biotechnology & Medical Research
OTC Markets Traded
| 1 day | +0.23% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Director of Finance/CFO | 59 | 2014-01-09 | |
Dag Nesse
CTO | Chief Tech/Sci/R&D Officer | 60 | 2023-01-31 |
Magnus Hansson
CTO | Chief Tech/Sci/R&D Officer | 50 | 2015-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 72 | 2017-11-05 | |
| Director/Board Member | 66 | 2017-04-26 | |
David Bejker
BRD | Director/Board Member | 51 | 2017-04-26 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 25-03-06 | Sell | Founder | 574,978 | 0.0357% | ||
| 25-03-06 | Sell | Founder | 574,978 | 0.0357% | ||
| 25-02-11 | Sell | Founder | 277,850 | 0.0172% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.23% | -1.11% | - | - | 76M | |
| +0.82% | -0.05% | +61.29% | +111.77% | 54.54B | |
| -1.22% | +5.01% | +43.38% | +36.69% | 43.86B | |
| -1.43% | +3.47% | -15.83% | -20.48% | 22.63B | |
| -1.99% | -3.55% | -5.97% | +377.60% | 20.7B | |
| -0.53% | +0.54% | +16.19% | -36.06% | 15.84B | |
| +1.83% | -1.59% | +9.82% | -40.10% | 14.83B | |
| -1.70% | -1.68% | +24.79% | +172.92% | 13.1B | |
| -5.17% | +0.50% | +21.80% | - | 12.66B | |
| +0.29% | +5.10% | +75.82% | +105.33% | 11.56B | |
| Average | -0.87% | +1.21% | +25.70% | +88.46% | 23.3B | |
| Weighted average by Cap. | -0.68% | +0.74% | +31.67% | +88.18% |
Employees
6
